论文信息 - The factor VIII heavy chain improves emicizumab-tenase assembly to enhance the factor VIII-mimicking cofactor activity. - 字舞流文

The factor VIII heavy chain improves emicizumab-tenase assembly to enhance the factor VIII-mimicking cofactor activity.

K. Nogami | M. Shima | K. Hattori | T. Kitazawa | T. Soeda | H. Minami

[1] K. Nogami,et al. Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens , 2017, Thrombosis and Haemostasis.

[2] Tetsuji Sato,et al. Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A. , 2016, The New England journal of medicine.

[3] T. Igawa,et al. Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity , 2013, PloS one.

[4] Tsukasa Suzuki,et al. A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model , 2012, Nature Medicine.

[5] P. Fay. Factor VIII Structure and Function , 2006, International journal of hematology.

[6] P. Fay. Activation of factor VIII and mechanisms of cofactor action. , 2004, Blood reviews.

[7] K. Nogami,et al. Altered Interactions between the A1 and A2 Subunits of Factor VIIIa following Cleavage of A1 Subunit by Factor Xa* , 2003, The Journal of Biological Chemistry.

[8] P. Fay,et al. Cleavage of Factor VIII Heavy Chain Is Required for the Functional Interaction of A2 Subunit with Factor IXa* , 2001, The Journal of Biological Chemistry.

[9] K. Koshibu,et al. The A2 Subunit of Factor VIIIa Modulates the Active Site of Factor IXa* , 1998, The Journal of Biological Chemistry.